Your source for the latest medtech news from AdvaMed® and our members.
Last week, AdvaMed® President and CEO Scott Whitaker and Semiconductor Industry Association (SIA) President and CEO John Neuffer hosted a joint roundtable discussion that included dozens of industry leaders and…
Today, the Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade organization representing medical technology manufacturers, released the following statements from President and CEO Scott Whitaker and Chairman of the…
This week, Healthcare Ready, whose mission is to “build and enhance” “strong infrastructure, seamless emergency response and supply chain coordination to ensure continuity of care”, honored AdvaMed® and the medtech industry as 2021 “Heroes…
February 9, 2022 — Canadian Hospital Specialties Limited (CHS) announced today that it has joined the Advanced Medical Technology Association® (AdvaMed®), the world’s leading trade association representing more than 400…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 206-225-5226
In a letter to President Joe Biden today, AdvaMed® President and CEO Scott Whitaker thanked the Administration for relaunching the Cancer Moonshot with an emphasis on cancer screening and advances…
AdvaMed® announced today that the nomination period for its 10th annual Lifetime Achievement Award is now open. The award will be presented at The Medtech Conference, which will be held in Boston in…
Hyalex Orthopaedics, a privately-held medical device company developing transformational cartilage biomimetic products, today announced the appointment of Carl Vause as its new chief executive officer and president.
Today, the Advanced Medical Technology Association® (AdvaMed®) responded to the Department of Commerce following the release of a report on a recent request for information on the semiconductor supply chain.…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Hyalex Orthopaedics, a privately-held medical device company developing transformational cartilage biomimetic products, today announced the appointment of Carl Vause as its new chief executive officer and president.